SCHEMBL8187735

SCHEMBL8187735

CCCC(=O)c1cnc2c(OCC[S+](C)[O-])cccc2c1Nc1ccc(C)cc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8190470 0.93 — —
SCHEMBL8188049 0.92 — —
SCHEMBL8187635 0.91 ATP4A (0.73) —
SCHEMBL8194310 0.88 ATP4A (0.60) —
SCHEMBL8193199 0.86 ATP4A (0.72) —
SCHEMBL8188919 0.86 — —
SCHEMBL8190097 0.85 — —
SCHEMBL9394652 0.85 ATP4A (0.66) —
SCHEMBL8177593 0.85 ATP4A (0.60) —
SCHEMBL8190801 0.85 ATP4A (0.68) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0702672-B1 SUBSTITUTED QUINOLINE DERIVATIVES AND THEIR USE AS INHIBITORS OF GASTRIC ACID SECRETION ASTRAZENECA AB (SE) 2000-09-06 — — EP disclosed
US-5889021-A GASTROINTESTINAL DISORDERS; ANTISECRETORY AGENTS; ANTIINFLAMMATORY AGENTS ASTRA AKTIEBOLAG (SE) 1999-03-30 — — US disclosed
US-5556863-A ANTIINFLAMMATORY AGENTS AND ANTISECRETORY AGENTS FOR GASTRIC JUICE ASTRA AKTIEBOLAG (SE) 1996-09-17 — — US disclosed
EP-0702672-A1 NEW ACTIVE COMPOUNDS AKTIEBOLAGET ASTRA (SE) 1996-03-27 — — EP disclosed
WO-1994029274-A1 NEW ACTIVE COMPOUNDS ASTRA AKTIEBOLAG (SE) 1994-12-22 — — WO disclosed
Send feedback